JW Pharmaceutical Corp (001067) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.132x

Based on the latest financial reports, JW Pharmaceutical Corp (001067) has a cash flow conversion efficiency ratio of 0.132x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩46.92 Billion ≈ $31.79 Million USD) by net assets (₩354.10 Billion ≈ $239.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 001067 company net worth for the company's overall valuation and market capitalisation.

JW Pharmaceutical Corp - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how JW Pharmaceutical Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.

JW Pharmaceutical Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of JW Pharmaceutical Corp ranked by their cash flow conversion efficiency. Explore JW Pharmaceutical Corp (001067) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
InTiCa Systems AG F:IS7	0.071x
La Savonnerie de Nyons SA PA:MLSDN	N/A
JX Luxventure Limited NASDAQ:JXG	-0.058x
Spago Nanomedical AB ST:SPAGO	-0.201x
Macarthur Minerals Ltd AU:MIO	-0.005x
Metals Creek Resources Corp V:MEK	-0.234x
Gaming Factory S.A. WAR:GIF	-0.051x
Compagnie des Eaux de Royan PA:MLEDR	N/A

Annual Cash Flow Conversion Efficiency for JW Pharmaceutical Corp (2014–2024)

The table below shows the annual cash flow conversion efficiency of JW Pharmaceutical Corp from 2014 to 2024. View JW Pharmaceutical Corp (001067) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩329.49 Billion ≈ $223.29 Million	₩79.39 Billion ≈ $53.80 Million	0.241x	-26.62%
2023-12-31	₩265.44 Billion ≈ $179.89 Million	₩87.16 Billion ≈ $59.07 Million	0.328x	+30.59%
2022-12-31	₩225.76 Billion ≈ $152.99 Million	₩56.76 Billion ≈ $38.47 Million	0.251x	+161.57%
2021-12-31	₩188.54 Billion ≈ $127.77 Million	₩18.12 Billion ≈ $12.28 Million	0.096x	-68.37%
2020-12-31	₩207.47 Billion ≈ $140.60 Million	₩63.05 Billion ≈ $42.73 Million	0.304x	+25.93%
2019-12-31	₩230.09 Billion ≈ $155.93 Million	₩55.53 Billion ≈ $37.63 Million	0.241x	+20.47%
2018-12-31	₩260.11 Billion ≈ $176.27 Million	₩52.11 Billion ≈ $35.31 Million	0.200x	+62.17%
2017-12-31	₩270.78 Billion ≈ $183.50 Million	₩33.45 Billion ≈ $22.67 Million	0.124x	+406.54%
2016-12-31	₩276.31 Billion ≈ $187.25 Million	₩6.74 Billion ≈ $4.57 Million	0.024x	+231.67%
2015-12-31	₩225.41 Billion ≈ $152.75 Million	₩-4.17 Billion ≈ $-2.83 Million	-0.019x	-155.99%
2014-12-31	₩220.02 Billion ≈ $149.11 Million	₩7.28 Billion ≈ $4.93 Million	0.033x	--

About JW Pharmaceutical Corp

KO:001067 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$7.03 Million

₩10.38 Billion KRW

Market Cap Rank

#27966 Global

#2060 in Korea

Share Price

₩50200.00

Change (1 day)

+0.00%

52-Week Range

₩41000.00 - ₩61500.00

All Time High

₩131401.16